Pharma News

prescriptions for mental health, CBD oil

50% of millennials would pick CBD oil over prescriptions for mental health

Eos Scientific has commissioned research across a sample of more than 2000 UK adults exploring the growing shift in health-conscious millennials seeking CBD oil over prescriptions for mental health.
cannabis businesses

Addressing how cannabis businesses are banked: Room for improvement?

With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.
europe canna expo

What is the Europe Canna Expo?

Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.
cbd oil revolution

CBD oil revolution: Introducing what it is and why the hype?

Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
rise of cannabidiol

A focus on the rise of cannabidiol (CBD)

George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD).
British hemp industry

Seeding the future of the British hemp industry

Rebekah Shaman, Managing Director at British Hemp Alliance takes a close look at the future of the British hemp industry in this article.
MS and Prostate Cancer, cannabinoids

Healing with cannabinoids: MS and Prostate Cancer

Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
myths about CBD

What are the most common myths about CBD?

Here, Paul Segal, chairman and co-founder of Symtomax, details what the most common myths about CBD are.

Why is it so hard to determine which CBD products to buy?

Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.
orphan designation

European Medicines Agency and orphan designation

Here, we discover that the European Medicines Agency works to foster scientific excellence in the evaluation and supervision of medicines for the benefit of public and animal health in the European Union.
the pharmaceutical industry

The pharmaceutical industry in Europe

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.
medical use of cannabinoids

Medical use of cannabinoids and marijuana

In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.
perspective on cannabidiol

A World Health Organization perspective on cannabidiol (CBD)

Here, we discover the World Health Organization perspective on cannabidiol (CBD), including how there has been a shift in how CBD is socially perceived following reports and recommendations.
medical cannabis market in denmark

The medical cannabis market in Denmark & Europe

Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.
cannabis vaporizers

Medical cannabis vaporizers

Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.
Bioavailibity

Bioavailibity: Oils, capsules, vapes, gummies and balms

Here, we have a brief look at the different methods of using CBD, and how each method affects bioavailability.
UK’s cannabis laws

What next for the UK’s cannabis laws?

John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.
medical cannabis & CBD

IP protection in fast-moving global markets: Medical cannabis & CBD

Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
cannabinoid extraction

From Cannabis flower to final products: Extractions for Phytopharmaceuticals

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
medicinal cannabis

Medicinal cannabis: What the UK can learn from Denmark

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.

Follow Open Access Government

Related Special Reports

Related eBooks